Results 171 to 180 of about 43,518 (188)

FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion

Journal of Cell Biology, 2005
Naciba Benlimame, Moulay A Alaoui-Jamali, Dingzhang Xiao   +2 more
exaly  

The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin

Oncogene, 1998
Ronit Pinkas-Kramarski, Yosef Yarden, Leah N Klapper   +2 more
exaly  

Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series

Bioorganic and Medicinal Chemistry Letters, 2006
Edgar R Wood, Robert A Mook, David W Rusnak   +2 more
exaly  

OVEREXPRESSION OF THE c-erbB-2 ONCOPROTEIN IN HUMAN BREAST CARCINOMAS: IMMUNOHISTOLOGICAL ASSESSMENT CORRELATES WITH GENE AMPLIFICATION

Lancet, The, 1987
W J Gullick
exaly  

The expression of p53, c-erbB-1 and c-erbB-2 molecules and their correlation with prognostic markers in patients with head and neck tumors

Cancer Letters, 2002
Mohammad Vasei, Helmout Modjtahedi, Bijan Khademi   +2 more
exaly  

C-ERBB-2 EXTERNAL DOMAIN: GP75

1991
STUART SUSAN G, MONAHAN JOHN J, LANGTON BEATRICE CLAUDIA, HANCOCK MIRIAM E C, CHAO LORRINE A, BLUFORD PETER   +5 more
openaire   +4 more sources

Untangling the ErbB signalling network

Nature Reviews Molecular Cell Biology, 2001
Yosef Yarden, Mark X Sliwkowski, Yarden Yosef   +2 more
exaly  

Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin

British Journal of Cancer, 2000
Xin Wei Wang, Anne W Hamburger, T A Gustafson   +2 more
exaly  

Hsp90 restrains ErbB‐2/HER2 signalling by limiting heterodimer formation

EMBO Reports, 2004
Ami Citri, Yaron Mosesson
exaly  

Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting

Molecular Immunology, 2012
Thomas Stockner, Josef Singer, Diana Mechtcheriakova   +2 more
exaly